Agilent Technologies, Inc. (A) NYSE

Currency In USD

AD

Agilent Technologies, Inc.

Address

5301 Stevens Creek Boulevard

Santa Clara, CA 95051

United States of America (the)

Phone

800 227 9770

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

18000

First IPO Date

November 18, 1999

Key Executives

NameTitlePayYear Born
Padraig McDonnellChief Executive Officer, President & Director2.64M1972
Rodney GonsalvesVice President of Finance832,0801966
Angelica RiemannSenior VP & President of Agilent CrossLab Group1.12M1971
Michael BucknerSenior Vice President, Chief Legal Officer, & Secretary1.18MN/A
Simon MaySenior VP and President of Life Sciences & Diagnostics Markets Group1.63M1973
Frederick SchwarzSenior VP, Chief Strategy & Corporate Development Officer0N/A
Tim DownsVP & Chief Accounting Officer01981
Adam S. ElinoffSenior Vice President, Chief Financial Officer & Principal Financial Officer01978
August SpechtSenior Vice President & Chief Technology Officer0N/A
Tejas Rajeev SavantVice President of Investor Relations0N/A
AD

Description

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

AD